NASDAQ · OSA
ProSomnus, Inc.
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
Loading market information…
OTC · ACHKF · USD
Stock price, earnings
Quote as of Jul 22, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Achiko AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Achiko AG, established in 2018 and based in Zurich, Switzerland, focuses on pioneering diagnostic technologies for both Indonesian and international markets. Its flagship innovation is AptameX, a rapid diagnostic test that identifies the SARS-CoV-2 virus by utilizing DNA aptamers, distinguishing it from traditional antigen-based methods. The company also offers Teman Sehat, a mobile application serving as a check-in and digital health passport. Additionally, under the Mimopay brand, Achiko AG provides secure payment processing, enabling game publishers and application developers to accept diverse payment methods for digital content and merchandise. The firm is also involved in the development of game software.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.47$0.00 (0.0%)
ProSomnus, Inc.’s quoted price sits in the lower half of its reported 52-week range, 6.0% below the high.
$0.07$0.00 (0.0%)
SugarBud Craft Growers Corp.’s quoted price sits in the lower half of its reported 52-week range, 77.44% below the high.
$0.00$0.00 (0.0%)
Medical Services International Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
FluroTech Ltd.: Healthcare · Medical - Devices.
$0.01+$0.01 (+100.0%)
Alseres Pharmaceuticals, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.82 (-99.99%)
Phoenix Life Sciences International Limited: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
NantHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.0% below the high.
CA$0.02+CA$0.01 (+50.0%)
Aquarius Surgical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.0% below the high.
